{"id":"https://openalex.org/W7202348958","doi":"https://doi.org/10.30895/2312-7821-2026-577","title":"Self-Medication with Tirzepatide for Weight Loss Resulting in Life-Threatening Conditions: A Clinical Case","display_name":"Self-Medication with Tirzepatide for Weight Loss Resulting in Life-Threatening Conditions: A Clinical Case","publication_year":2026,"publication_date":"2026-08-13","ids":{"openalex":"https://openalex.org/W7202348958","doi":"https://doi.org/10.30895/2312-7821-2026-577"},"language":"en","primary_location":{"id":"doi:10.30895/2312-7821-2026-577","doi":"https://doi.org/10.30895/2312-7821-2026-577","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-577","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.30895/2312-7821-2026-577","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103107775","display_name":"E V Dovgan","orcid":"https://orcid.org/0000-0002-2655-6192","observed_orcids":["https://orcid.org/0000-0002-2655-6192"]},"institutions":[{"id":"https://openalex.org/I4210094660","display_name":"Regional State Budgetary Healthcare Institution \"Smolensk Regional Clinical Hospital\"","ror":"https://ror.org/00p75zw90","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210094660"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. V. Dovgan","raw_affiliation_strings":["Smolensk Regional Clinical Hospital"],"raw_orcid":"https://orcid.org/0000-0002-2655-6192","affiliations":[{"raw_affiliation_string":"Smolensk Regional Clinical Hospital","institution_ids":["https://openalex.org/I4210094660"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090305265","display_name":"Irina V. Andreeva","orcid":"https://orcid.org/0000-0001-7916-1488","observed_orcids":["https://orcid.org/0000-0001-7916-1488"]},"institutions":[{"id":"https://openalex.org/I4210120801","display_name":"Smolensk State Medical University","ror":"https://ror.org/02wwnew71","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120801"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. V. Andreeva","raw_affiliation_strings":["Smolensk State Medical University"],"raw_orcid":"https://orcid.org/0000-0001-7916-1488","affiliations":[{"raw_affiliation_string":"Smolensk State Medical University","institution_ids":["https://openalex.org/I4210120801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157967887","display_name":"S. Yu. Anisimova","orcid":"https://orcid.org/0009-0000-8613-4197","observed_orcids":["https://orcid.org/0009-0000-8613-4197"]},"institutions":[{"id":"https://openalex.org/I4210094660","display_name":"Regional State Budgetary Healthcare Institution \"Smolensk Regional Clinical Hospital\"","ror":"https://ror.org/00p75zw90","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210094660"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"S. Yu. Anisimova","raw_affiliation_strings":["Smolensk Regional Clinical Hospital"],"raw_orcid":"https://orcid.org/0009-0000-8613-4197","affiliations":[{"raw_affiliation_string":"Smolensk Regional Clinical Hospital","institution_ids":["https://openalex.org/I4210094660"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009861603","display_name":"V.\u0410. Andreev","orcid":"https://orcid.org/0009-0007-1535-9242","observed_orcids":["https://orcid.org/0009-0007-1535-9242"]},"institutions":[{"id":"https://openalex.org/I4210120801","display_name":"Smolensk State Medical University","ror":"https://ror.org/02wwnew71","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120801"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. A. Andreev","raw_affiliation_strings":["Smolensk State Medical University"],"raw_orcid":"https://orcid.org/0009-0007-1535-9242","affiliations":[{"raw_affiliation_string":"Smolensk State Medical University","institution_ids":["https://openalex.org/I4210120801"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013117568","display_name":"Valentina M. Tsareva","orcid":"https://orcid.org/0000-0003-0835-3073","observed_orcids":["https://orcid.org/0000-0003-0835-3073"]},"institutions":[{"id":"https://openalex.org/I4210120801","display_name":"Smolensk State Medical University","ror":"https://ror.org/02wwnew71","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120801"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. M. Tsareva","raw_affiliation_strings":["Smolensk State Medical University"],"raw_orcid":"https://orcid.org/0000-0003-0835-3073","affiliations":[{"raw_affiliation_string":"Smolensk State Medical University","institution_ids":["https://openalex.org/I4210120801"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"3","first_page":"278","last_page":"289"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.6190999746322632,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.6190999746322632,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.12349999696016312,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":0.09690000116825104,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/self-medication","display_name":"self-medication","score":0.9330000281333923},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8730000257492065},{"id":"https://openalex.org/keywords/gip-receptor-agonist","display_name":"GIP receptor agonist","score":0.9660000205039978},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7599999904632568},{"id":"https://openalex.org/keywords/adverse-drug-interactions","display_name":"adverse drug interactions","score":0.7760000228881836},{"id":"https://openalex.org/keywords/serotonin-syndrome","display_name":"serotonin syndrome","score":0.9079999923706055},{"id":"https://openalex.org/keywords/extrapyramidal-disorders","display_name":"extrapyramidal disorders","score":0.9470000267028809},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/rhabdomyolysis","display_name":"rhabdomyolysis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/electrolyte-imbalance","display_name":"electrolyte imbalance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/metoclopramide","display_name":"metoclopramide","score":0.871999979019165},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":0.972000002861023},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.7269999980926514},{"id":"https://openalex.org/keywords/bisoprolol","display_name":"bisoprolol","score":0.996999979019165},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8522999882698059},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.64410001039505},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6362000107765198},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.5376999974250793},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5306000113487244},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4754999876022339},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46560001373291016},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.4352000057697296},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43459999561309814},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4221000075340271},{"id":"https://openalex.org/C2778479196","wikidata":"https://www.wikidata.org/wiki/Q421095","display_name":"Metoclopramide","level":3,"score":0.3919000029563904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39070001244544983},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.36959999799728394},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C2777929519","wikidata":"https://www.wikidata.org/wiki/Q7144988","display_name":"Patient education","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.3237000107765198},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.31940001249313354},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.3188999891281128},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.30550000071525574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3027999997138977},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.29100000858306885},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.2596000134944916}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.30895/2312-7821-2026-577","doi":"https://doi.org/10.30895/2312-7821-2026-577","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-577","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:373f9a4e7fca4e35968ec7fc9f5271ae","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/373f9a4e7fca4e35968ec7fc9f5271ae","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0411\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u044c \u0438 \u0440\u0438\u0441\u043a \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438, Vol 14, Iss 3, Pp 278-289 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.30895/2312-7821-2026-577","doi":"https://doi.org/10.30895/2312-7821-2026-577","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-577","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W28790285","https://openalex.org/W1762116981","https://openalex.org/W2001211061","https://openalex.org/W2006527949","https://openalex.org/W2042160262","https://openalex.org/W2047272173","https://openalex.org/W2092475629","https://openalex.org/W2105067969","https://openalex.org/W2139310420","https://openalex.org/W2403882174","https://openalex.org/W2756947392","https://openalex.org/W2897608137","https://openalex.org/W2901297117","https://openalex.org/W2954617549","https://openalex.org/W3015139457","https://openalex.org/W3133192489","https://openalex.org/W3192281797","https://openalex.org/W4206592693","https://openalex.org/W4206807142","https://openalex.org/W4225286235","https://openalex.org/W4252928828","https://openalex.org/W4284991008","https://openalex.org/W4285087957","https://openalex.org/W4294578232","https://openalex.org/W4310668500","https://openalex.org/W4324103364","https://openalex.org/W4368617544","https://openalex.org/W4385342505","https://openalex.org/W4385978034","https://openalex.org/W4398223220","https://openalex.org/W4399273336","https://openalex.org/W4407183277","https://openalex.org/W4410075238","https://openalex.org/W4410711964","https://openalex.org/W4411347417","https://openalex.org/W4412389896","https://openalex.org/W4412522316","https://openalex.org/W4412840955","https://openalex.org/W4412984788","https://openalex.org/W4415376700","https://openalex.org/W4416980987","https://openalex.org/W4417105967","https://openalex.org/W7126099167","https://openalex.org/W7135018644","https://openalex.org/W7148627665","https://openalex.org/W7151770115"],"related_works":["https://openalex.org/W4403721114","https://openalex.org/W4417108613","https://openalex.org/W4387752027","https://openalex.org/W7163080796","https://openalex.org/W4390952355","https://openalex.org/W4398138753","https://openalex.org/W4324120940","https://openalex.org/W4408093692","https://openalex.org/W4409619378","https://openalex.org/W6930683945"],"abstract_inverted_index":{"INTRODUCTION.":[0],"Glucagon-like":[1],"peptide-1":[2],"(GLP-1)":[3],"and":[4,24,31,45,108,118,129,137,153,200,236,243],"glucose-dependent":[5],"insulinotropic":[6],"polypeptide":[7],"(GIP)":[8],"receptor":[9,230],"agonists":[10,231],"are":[11],"used":[12],"for":[13,240],"the":[14,42,56,69,104,132,171,193,215,224,233,238,248,252],"treatment":[15],"of":[16,51,59,65,91,97,103,167,177,188,202,209,217,226,228,254],"type":[17,84],"2":[18,81,85],"diabetes":[19,86],"mellitus,":[20],"obesity,":[21],"weight":[22,25],"reduction,":[23],"control.":[26],"Owing":[27],"to":[28,93,114,123,191,197,214],"their":[29,52],"weight-loss":[30],"appetite-suppressant":[32],"effects,":[33],"information":[34],"about":[35,247],"these":[36],"agents":[37],"has":[38],"spread":[39],"widely":[40],"in":[41,139,232,251],"mass":[43,234],"media":[44,235],"social":[46],"networks.":[47],"A":[48,75],"notable":[49],"aspect":[50],"use":[53,187],"worldwide":[54],"is":[55],"widespread":[57],"practice":[58],"self-medication.":[60],"We":[61],"present":[62],"a":[63,112,175],"case":[64,222],"off-label":[66],"self-medication":[67],"with":[68,127,159],"prescription":[70,105,189],"drug":[71,125,182,211],"tirzepatide.":[72],"CASE":[73],"REPORT.":[74],"51-year-old":[76],"woman":[77],"(BMI":[78],"22.9":[79],"kg/m":[80],",":[82],"without":[83,110,195,207],"mellitus)":[87],"self-injected":[88],"5":[89,168],"mg":[90,169],"tirzepatide":[92,160],"lose":[94],"2\u20133":[95],"kg":[96],"body":[98],"weight.":[99],"The":[100,184],"subsequent":[101,185],"self-administration":[102],"medications":[106,190],"metoclopramide":[107],"furosemide":[109],"consulting":[111],"physician":[113,241],"relieve":[115,192],"nausea,":[116],"vomiting,":[117],"elevated":[119],"blood":[120],"pressure":[121],"led":[122,213],"adverse":[124,181],"interactions":[126],"fluoxetine":[128],"bisoprolol,":[130],"which":[131],"patient":[133,245],"was":[134,170],"taking":[135],"regularly,":[136],"resulted":[138],"multiple":[140],"life-threatening":[141,218],"conditions":[142],"(extrapyramidal":[143],"disorders,":[144],"serotonin":[145],"syndrome,":[146],"severe":[147,180],"electrolyte":[148],"disturbances,":[149],"QTc":[150],"interval":[151],"prolongation,":[152],"rhabdomyolysis)":[154],"requiring":[155],"hospitalization.":[156],"CONCLUSIONS.":[157],"Self-medication":[158],"at":[161],"an":[162],"inadequately":[163],"high":[164],"starting":[165],"dose":[166],"trigger":[172],"that":[173],"initiated":[174],"cascade":[176],"predictable":[178],"but":[179],"reactions.":[183],"uncontrolled":[186],"symptoms":[194],"adherence":[196],"dosage":[198],"regimens":[199],"frequency":[201],"administration,":[203],"as":[204,206],"well":[205],"consideration":[208],"potential":[210],"interactions,":[212],"development":[216],"conditions.":[219],"This":[220],"clinical":[221],"highlights":[223],"problem":[225],"popularization":[227],"GLP-1/GIP":[229],"underscores":[237],"need":[239],"supervision":[242],"proactive":[244],"education":[246],"risks,":[249],"especially":[250],"presence":[253],"concomitant":[255],"pharmacotherapy.":[256]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-08-14T00:00:00"}